Cite
Current and emerging therapies for localized high-risk prostate cancer.
MLA
Moris, Lisa, et al. “Current and Emerging Therapies for Localized High-Risk Prostate Cancer.” Expert Review of Anticancer Therapy, vol. 21, no. 3, Mar. 2021, pp. 267–82. EBSCOhost, https://doi.org/10.1080/14737140.2021.1852932.
APA
Moris, L., Devos, G., Van den Broeck, T., Milonas, D., Albersen, M., Berghen, C., De Meerleer, G., Devlies, W., Everaerts, W., Gevaert, T., Van Poppel, H., Claessens, F., & Joniau, S. (2021). Current and emerging therapies for localized high-risk prostate cancer. Expert Review of Anticancer Therapy, 21(3), 267–282. https://doi.org/10.1080/14737140.2021.1852932
Chicago
Moris, Lisa, Gaëtan Devos, Thomas Van den Broeck, Daimantas Milonas, Maarten Albersen, Charlien Berghen, Gert De Meerleer, et al. 2021. “Current and Emerging Therapies for Localized High-Risk Prostate Cancer.” Expert Review of Anticancer Therapy 21 (3): 267–82. doi:10.1080/14737140.2021.1852932.